Genetic polymorphism (mainly CYP2C19*2,CYP2C19*3 and CYP2C19*17)exists for CYP2C19expression, with approximately 3–5% of Caucasian and 15–2% of Asian populations being poor metabolizers with no CYP2C19 function. This may reduce the efficacy of clopidogrel (Plavix). In patients with an abnormal
Sample Type - Blood
Reporting Time - Please Call Customer care
Prerequisites - No special preparation required
Price - ₹9990/-
Add to cart Go Home